110-52-1 + 22246-18-0 = 129722-34-5 + 882880-12-8 反应条件:1.1 Reagents: Potassium Carbonate Solvents: Methyl Ethyl Ketone; 75 °C 标题:Efficient Synthesis Of Deuterium Labeled Hydroxyzine And Aripiprazole 作者:Vohra,Mohit; Et Al 参考文献:Journal Of Labelled Compounds And Radiopharmaceuticals 日期:2015 卷标:58(7) 页码:304-307]
6940-78-9 + 22246-18-0 = 129722-34-5 + 882880-12-8 + 120004-79-7 + 2295935-56-5 反应条件:1.1 Reagents: Potassium Carbonate Solvents: Dimethylformamide; 24 H,20 - 30 °C 标题:Industry-Oriented Route Evaluation And Process Optimization For The Preparation Of Brexpiprazole 作者:Chen,Weiming; Et Al 参考文献:Organic Process Research & Development 日期:2019 卷标:23(5) 页码:852-857
专利号:US-2007149782-A1 优先权日:2005-12-23 标 题:Methods of preparing a crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1h)-quinolinone and the use thereof in the synthesis of Aripiprazole 发明人:BRAND MICHAEL; SHOOKRUN MOTY; GRIBUN IRINA; ADIN ITAI; IUSTAIN CARMEN; BRAVERMAN OLEG; UDIS NATALIA; ARAD ODED; KASPI JOSEPH 权利人:BRAND MICHAEL; SHOOKRUN MOTY; GRIBUN IRINA; ADIN ITAI; IUSTAIN CARMEN; BRAVERMAN OLEG; UDIS NATALIA; ARAD ODED; KASPI JOSEPH 摘要:The present invention relates to methods of preparing a highly pure crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1H)-quinolinone, which is a chemical intermediate useful in the preparation of Aripiprazole thereof in high quality and yield, and provides data that characterizes the crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-(1H)-quinolinone.
专利号:US-9795685-B2 优先权日:2012-08-21 标 题 :Haptens of aripiprazole 发明人:LIN RONGHUI; SALTER RHYS; DECORY THOMAS R; HRYHORENKO ERIC; REMMERIE BART M; SANKARAN BANUMATHI 权利人:JANSSEN PHARMACEUTICA NV 摘要:The invention relates to compounds of Formula I, wherein R 1 , R 2 , and R 3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to conjugates of an aripiprazole hapten and a protein.
专利号:US-9951088-B2 优先权日:2012-05-09 标题 :D2 receptor modulators and methods of use thereof in the treatment of diseases and disorders 发明人:JONES PHILIP G; LEW ROBERT; SPEAR KERRY L; XIE LINGHONG 权利人:SUNOVION PHARMACEUTICALS INC 摘要:Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and neurological disorders, including, but not limited to, e.g., psychosis, schizophrenia, depression, movement disorders, and Parkinson's disease.
专利号:US-2005215791-A1 优先权日:2004-02-05 标题:Process for preparing aripiprazole 发明人:DOLITZKY BEN-ZION; LERMAN ORI 权利人:DOLITZKY BEN-ZION; LERMAN ORI 摘要:The invention encompasses the synthesis of aripiprazole from BBQ and DCP, and comprises mixing 7-(4-bromobutoxy)-3,4-dihydrocarbostyril (BBQ) and 1-(2,3-dichlorophenyl)piperazine hydrochloride (DCP) in the presence of at least one base and at least one organic solvent to form a reaction mixture; heating the reaction mixture for a sufficient amount of time to effect the reaction; and isolating aripiprazole. The invention also encompasses the use of phase transfer catalysts in synthesizing aripiprazole from BBQ and DCP.
专利号:US-11453670-B2 优先权日:2018-06-11 标 题:Substituted heterocycle fused gamma-carbolines synthesis 发明人:LI PENG; ZHANG QIANG 权利人:INTRA CELLULAR THERAPIES INC 摘要:The present invention provides improved methods for the preparation of substituted heterocycle fused gamma-carbolines, intermediates useful in producing them and methods for producing such intermediates and such heterocycle fused gamma-carbolines.
专利号:CN-113214150-A 优先权日:2021-04-20 标 题:A kind of synthesis of high-purity aripiprazole and preparation method of hydrate microparticles
参考标题:The One-Pot Synthesis Of Butyl-1H-Indol-3-Alkylcarboxylic Acid Derivatives In Ionic Liquid As Potent Dual-Acting Agent For Management Of Bph 作者:Li-Yan Zeng,Fubiao Yang,Kaixuan Chen,Yunong Zeng,Zhenzhou Jiang,Shuwen Liu,Baomin Xi |发布日期:2020.11 摘要:H-Indol-3-Yl)Butanoic Acid 4Aaa Was Designed Against Bph And Synthesized By Two Steps Of N-Alkylation. One-Pot Protocol Towards 4Aaa Was Newly Developed. With Il [c6Min]Br As Solvent, The Yield Of 4Aaa Was Increased To 75.1 % From 16.0 % And The Reaction Time Was Shortened In 1.5 Hours From 48 Hours. 25 Derivatives Structurally Based On Arylpiperazine And Indolyl Butyric Acid With Alkyl Linker Were